Allergy Immunotherapy Market is expected to reach USD 4,355.24 Million by 2028 : Cognitive Market Research

Market Overview:
• Immunotherapy is a treatment to develop antibodies against an allergen to reduce its severity and improve the functioning of immune system, so that it is able to recognize, target and eliminate cells in the body. Allergy immunotherapy is also known as allergic shots that are regular injections given to patient to reduce allergy attacks. Allergy shots has tiny amount of specific allergen that triggers the allergic reaction. These medications stimulate immune system. The immune system on getting allergic shots builds up tolerance to the allergens reducing the intensity and frequency of allergic reactions. The allergic reactions caused due to house dust mites, food allergens, birch tree, ragweed, grass, insect venom, animal dander pollen grains. The common symptoms observed in the allergic reactions are wheezing, difficulty in breathing, coughing, watery eyes, stuffy nose, itchy eyes.

Market Insights:
• The Global Allergy Immunotherapy Market is expected to reach USD 4,355.24 Million by the end of 2028, growing at a CAGR of 10.98% between 2021 and 2028.
• The North America Allergy Immunotherapy market size is projected to reach USD 1,295.47 Million in 2028.

"To know more The Allergy Immunotherapy Market Insights click here: https://www.cognitivemarketresearch.com/allergy-immunotherapy-market-report

Market Drivers:
• Rising prevalence of Allergies:
Increasing exposure towards allergens is the major factor responsible for the rising prevalence of allergies. Additionally, rate of food allergies across the globe has also increased from around 3% of the population in 1960 to around 7% in 2018. Moreover, the range of foods to which people are allergic has also widened. One large-scale review of hospital admissions data found anaphylaxis cases on the rise in the US, Australia and Europe, among other regions. In the US, hospital visits for food allergy increased threefold from 1993 to 2006. Further, increasing use of certain medications contribute to the increase in asthma as increased antibiotic use parallels the rise in allergy and asthma. Change in lifestyle and increased pollution level contributes majorly on rising prevalence of allergies.
• Technological Advancements in medical field:

With the advent of technology, the treatment for the disorders has been improved, which is one of the major aspects which boost the growth of the market for the allergy immunotherapy across the globe. Prevalence of chronic disorders have been increasing at a pace and people are taking wide array of drugs for their treatment. Demand for sophisticated and long-term treatment options is increasing. These drugs cause various allergies affecting immune system of patients. This is the major factor responsible for the growth of allergy immunotherapy market. For instance, oncology devices have evolved over the years, owing to product enhancements and application of information, stereotactic, and sensing technologies in this sector. Players are constantly investing in their R&D sector to introduce products that are both low cost and highly efficient.
• Restraints for Allergy Immunotherapy Market
Rapid rise in the change in technology
• Opportunities for Allergy Immunotherapy Market
Rising Healthcare Expenditure:

Market Segmentation:
Type
• Allergic Rhinitis
Allergic rhinitis is an allergic reaction caused due to harmless allergen. The symptoms of allergic rhinitis include sneezing, runny, stuffy nose, coughing, watery eyes, eczema type symptoms, itchy eyes. The allergic rhinitis is caused due to ragweed allergen, sublingual allergen tablet administered in the treatment with or without conjunctivitis.
• Allergic Asthma
The allergic asthma is an allergen causes reaction in lungs that leads to difficulty in breathing, wheezing. The allergic asthma reaction occurs due to birch trees, house dust mites, ragweed, pollen grains, animal dander allergens. The subcutaneous allergy shot treatment is also effective to treat allergic asthma.
• Food Allergy
• Atopic Dermatitis
• Others

Treatment Type
• Sublingual Immunotherapy
Sublingual immunotherapy is a treatment to treat allergies in cancer patients creating antibodies against infection and reduce intensity of allergic reaction. The sublingual immunotherapy is treated by placing a tablet under tongue, drug is administered by passing the gastrointestinal tract.
• Subcutaneous Immunotherapy
Allergy shots or injection is inserted into skin through parenteral route. The small amount of allergen is injected into skin of the arm. thigh. The subcutaneous therapy is indicated for allergic conditions such as allergic rhino conjunctivitis, allergic otitis media, bronchial asthma.

Allergy Type
• Birch/Tree Allergy
• Ragweed Allergy
• Grass Allergy
• House Dust Mite Allergy
• Insect Venom Allergy
• Animal Dander
• Others

Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Get free sample pages of latest published Allergy Immunotherapy Report:
https://www.cognitivemarketresearch.com/allergy-immunotherapy-market-report/report_enquiry/4

Competitive Analysis for Allergy Immunotherapy Market:
Stallergenes Greer, HAL Allergy Holding B.V., Allergy Therapeutics, DBV Technologies, Aimmune Therapeutics Inc, Allergopharma (Derma pharm AG), Biomay AG, Anergis SA, ALK

ALK
• ALK is a based in Denmark and is pharmaceutical company focused on allergy and allergic asthma. The company offered wide range of allergy immunotherapy treatments and other products and services which meet the unique needs of allergy sufferers, their families and healthcare professionals. The company provide various solutions such as diagnosing allergy, allergy vaccines and emergency medicine.

Recent News:
• September 2019
Germany becomes first launch market for ALK's tree SLIT-tablet
ALK has confirmed the first launch of its sublingual allergy immunotherapy (SLIT) tablet, ITULAZAX®, in Germany, after the company received national approval from authorities. These product branded ITULAZAX® is indicated for the treatment of tree pollen allergy.

Related Report:
• Allergy Vaccine Market - https://www.cognitivemarketresearch.com/allergy-vaccine-market-report
• Allergy Diagnostic Market - https://www.cognitivemarketresearch.com/allergy-diagnostic-market-report
• Allergy and Sinus Medicine Supplements Market - https://www.cognitivemarketresearch.com/allergy-and-sinus-medicine-supplements-market-report

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Nicolas Shaw
Cognitive Market Research
20 N State Street,Chicago,
Illinois, 60602
United States
USA: +1 312-376-8303
Europe and UK: (+44) 20-8144-9523
Asia Pacific: (+852) 81930785
Email: sales@cognitivemarketresearch.com
Website: https://www.cognitivemarketresearch.com/about-us

About Cognitive Market Research Company :
Cognitive Market Research has evolved as one leading market research and consulting firm and it provides services across multiple domains. Cognitive Market Research gathers and analyzes data about customers, competitors, distributors, and other market actors and forces operational across the value chain. As a market research company, we follow a complete process of gathering information about the target market and end-use industries to verify the complete journey of the product or service in the global market. It helps our readers understand the demand and viability of their product/service and how it might perform in the real world and help them to build business strategies accordingly.

This release was published on openPR.